The Effect of Early Versus Standard Central Line Removal on Growth of Very Low Birth Weight Prema… (NCT03730883) | Clinical Trial Compass
UnknownNot Applicable
The Effect of Early Versus Standard Central Line Removal on Growth of Very Low Birth Weight Premature Infants
Poland214 participantsStarted 2019-01-26
Plain-language summary
This study compares two different regimens of a central line removal in respect to weight at 36 weeks postmenstrual age in very low birth weight (VLBW) preterm infants. Half of participants will have a central line removed at ≥100 ml/kg/d, while the other half will have a central line removed at ≥ 140 ml/kg/day.
Who can participate
Age range
2 Weeks
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Birth weight ≤ 1500 g (very low birth weight).
. Birth weight ≥ 3rd percentile at a given gestational age.
. Central line inserted (PICC or UVC).
. Oral intake not exceeding 100 ml/kg/d at randomization.
. Lack of congenital illness or malformation that may affect growth.
. Signed parental consent.
Exclusion criteria
. Birth weight \> 1500 g.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Weight at 36 weeks PMA.
Timeframe: 36 weeks PMA.
Trial details
NCT IDNCT03730883
SponsorPrincess Anna Mazowiecka Hospital, Warsaw, Poland